Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001370368-25-000010
Filing Date
2025-04-29
Accepted
2025-04-29 06:01:32
Documents
6
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 6-K a250429-6k.htm 6-K 13918
2 99.1 FINANCIAL REPORT Q1 2025 a250429-99_1.htm EX-99 160861
3 99.2 CONDENSED FINANCIAL REPORT a250429-99_2.htm EX-99 817166
4 IMAGE letterheadpr.jpg GRAPHIC 25357
5 IMAGE logorm.jpg GRAPHIC 29788
6 IMAGE coverifr.jpg GRAPHIC 118384
  Complete submission text file 0001370368-25-000010.txt   1220418
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 25882457
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)